Johnson & Johnson stock slips on Trump drug-price pact as tariff relief comes into view
New York, Jan 9, 2026, 14:40 (EST) — Regular session Johnson & Johnson shares slipped about 0.5% to $204.76 on Friday after the company said it struck an agreement with President Donald Trump’s administration to lower drug prices for Americans in return for exemptions from U.S. tariffs. Johnson & Johnson did not say which medicines are included or how large the price cuts would be. (Reuters) The update is in focus as drugmakers face pressure to shrink the gap between U.S. prices and those in other wealthy countries, and Washington has dangled tariff relief — import duties that can raise